Repurposing passenger amplifications as Trojan horses identifies MPZL1 as a potent target for solid cancers
Sonia Jiménez Vázquez, Christos Patsis, Mara Mitstorfer…·Darjus Felix Tschaharganeh
The paper identifies MPZL1 as a therapeutic target in 1q-amplified solid cancers by repurposing passenger amplifications as Trojan horses for targeted therapy delivery.